Weekly Psychedelic Links

This Week in Psychedelics - 4.24.20

ThisWeekinPsychedelics.png

Cannabis

  • Lebanon Passes Legislation Legalizing Medical Marijuana Cultivation As Economy Struggles Amid Coronavirus Fallout (Newsweek)

  • Mexican Supreme Court Again Extends Marijuana Legalization Deadline (Marijuana Moment)

  • Due to COVID-19, Connecticut’s Legislative Session Cut Short, Cannabis Legalization Stalled (Cannabis Wire)

  • On 4/20, ACLU Highlights Racist Marijuana Enforcement In New Report (Forbes)

  • Virginia Lawmakers Reject Governor’s Delay Of Marijuana Legalization Study (Marijuana Moment)

  • Scotland is set to get its first legal cannabis farm to produce drug for use in medicine (The Scottish Sun)

  • Majority Of Americans Think Marijuana Legalization Is A Successful Policy, Poll Finds (Marijuana Moment)

  • Americans Think Cannabis Is Safer Than Alcohol, But Social Stigmas Remain (MERRY JANE)

  • Early exposure to cannabis boosts young brains' sensitivity to cocaine, rodent study finds (Science Daily)

  • New Jersey Voters Set To Approve Marijuana Legalization Referendum, Poll Shows (Marijuana Moment)

  • Clinical Trials for Treating COVID-19 with Cannabis Begin in Israel (MERRY JANE)

  • Everything to Know About Cannabis and Coronavirus (The Cut)

  • Cannabis industry launches COVID-19 relief efforts in Colorado (KDVR)

  • DEA Marijuana Scheduling Lawsuit Will Be Appealed To Supreme Court Following Dismissal (Marijuana Moment)

  • 24 Million Americans Will Spend Stimulus Check on Weed or Booze, Survey Says (MERRY JANE)

  • New Jerseyans back referendum to legalize weed by huge margin, new poll shows (New Jersey Globe)

  • Lawmakers File Bill To Let Marijuana Businesses Access Federal Coronavirus Relief Funds (Marijuana Moment)

  • Feast or famine: The effect of marijuana on weight (The Spokesman-Review)

  • Smoking Weed Causes Less DNA Damage Than Tobacco, Study Finds (MERRY JANE)

  • There is no difference between the effects of indica and sativa marijuana strains, scientists say (Insider)

  • Weed advocacy groups call for prison depopulation to slow COVID-19 spread (Mugglehead)

LSD

  • Mick Jagger once bought a giant mansion while tripping on LSD (Far Out Magazine)

Magic Mushrooms

  • Until Next Time: California’s Mushroom Decriminalization Effort Ends (Filter)

  • Empower Clinics launches psilocybin research and psychedelic treatment subsidiary (Proactive Investors)

  • Champignon secures stable psilocybin supply for traumatic brain injury, PTSD studies at the University of Miami (Proactive Investors)

  • Two New Crystalline Forms of Norpsilocin (Psychedelic Science Review)

Ketamine

  • Defense Department Approves Ketamine-Based Antidepressant for Some Patients (Military.com)

  • Utah Clinician Exemplifies Innovation in Ketamine Therapy (Lucid News)

Miscellaneous

  • D.C. Would Vote To Decriminalize Psychedelics, Poll Shows (Forbes)

  • Medical Researchers Worry Silicon Valley Could Screw Up Psychedelics (OneZero)

  • Thiel Backs Psychedelic-Drug Startup in Latest Funding Round (Bloomberg)

  • The Prohibited Medicine (Medium)

  • Why Dark-Web Drug Marketplaces Can Be a Refuge (Filter)

  • The Structure and Function of the Serotonin 5-HT2C Receptor (Psychedelic Science Review)

  • How the Illicit Drug Trade Is Adapting to the Coronavirus Pandemic (World Politics Review)

  • UN Experts Agree – The Right to Health of People Who Use Drugs Must Be Prioritised in Global COVID-19 Response (TalkingDrugs)

  • Welcome to Entheogen (Medium)

  • Psychedelics Make a Comeback as Therapies for Brain Injury, PTSD, Anxiety and Even Addiction (BioSpace)

  • Can Psychedelics Treat Climate Grief? (The Nation)

  • Russian NGO Accused of “Narco-Propaganda” Over COVID-19 Advocacy For People Who Use Drugs (TalkingDrugs)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.17.20

ThisWeekinPsychedelics.png

Cannabis

  • Virginia: Governor Approves Bills to Decriminalize Marijuana and Legalize Medical Cannabis (NORML)

  • DC Allows Medical Marijuana Delivery Under Coronavirus Emergency Order (Marijuana Moment)

  • N.F.L. Bows to Marijuana’s New Status (The New York Times)

  • Missouri Activists Officially End 2020 Marijuana Legalization Campaign Due To Coronavirus (Marijuana Moment)

  • 420 Smoke-Out Is Officially Canceled in San Francisco Due to Coronavirus (MERRY JANE)

  • UK’s First Virtual Cannabis Legalisation Rally to be Held on 4/20 (The Cannabis Exchange)

  • How To Celebrate The 4/20 Marijuana Holiday Virtually This Year Amid COVID Social Distancing (Marijuana Moment)

  • COVID-19 delays Maine’s recreational marijuana rollout (Leafly)

  • House Democrats Working to Roll Cannabis Banking Into Coronavirus Relief Effort (MERRY JANE)

  • No federal relief: Cannabis businesses cry for help as coronavirus batters industry (NBC News)

  • Virginia Governor Urges Medical Marijuana Expansion As Amendment To Recently Approved Bill (Marijuana Moment)

  • A.I. Suggests US Vaping Illness Case From Last Summer Was Actually COVID-19 (MERRY JANE)

  • Montana Marijuana Activists File Lawsuit For Electronic Ballot Signature Gathering During COVID (Marijuana Moment)

  • Rare cannabinoid shows early promise for diabetes (Leafly)

  • Marijuana Use Reaches All-Time High Under Coronavirus Pandemic (The Fresh Toast)

  • Hemp Farmers Make Double the Salary of Average Agricultural Workers, Study Says (MERRY JANE)

  • Cannabis May Ease Opioid Withdrawal Symptoms, Johns Hopkins Study Finds (Marijuana Moment)

  • Study suggests frequency and severity of negative reactions to cannabis (Medical News Today)

  • DEA Seized More Marijuana Plants In 2019, But Arrests Fell (Marijuana Moment)

  • ‘Cooked With Cannabis’ takes pot-infused cuisine to new highs (Chicago Sun Times)

  • USDA Approves Hemp Plans For Florida, Kansas And Three Indian Tribes (Marijuana Moment)

  • Medical Cannabis and Arthritis – Could it Help? (The Cannabis Exchange)

  • Does cannabis make you poo? (Leafly)

LSD

  • Indie Film ‘Debbie and Doug Drop Acid in the Desert’ is a Visual and Emotional Trip (Psymposia)

  • Bicycle Day: Demons, Milk, and “Medicine for the Soul” (DoubleBlind)

Magic Mushrooms

  • Neuroscientists uncover how magic mushrooms "rebalance" the brain (Inverse)

  • Psychedelic compound from magic mushrooms produced in yeast (Phys.org)

  • Science breakthrough: How ancient humans used magic mushrooms to grow brains exposed (Express)

  • Orthogonal Thinker Files For Patent For Its Psilocybin Product, Psilly (Benzinga)

  • Psilocybin Mushrooms Are Making A Comeback (Longevity Live)

  • How to Make Mushroom Chocolates (DoubleBlind)

MDMA

  • Scientists say MDMA could help treat mental health in a post-lockdown world (Dazed)

DMT

  • What Is DMT "Changa" and How Do You Make This Form of the Psychedelic? (MERRY JANE)

Ayahuasca

  • Coloradan Gets Stuck at Ayahuasca Retreat in Peru (Westword)

  • How Ayahuasca, an Ancient Amazonian Hallucinogen, Became Hollywood's New Favorite Escape (Town & Country)

  • The Virus, Ayahuasca, Grief, and Hope (Chacruna)

5-MeO-DMT

Iboga

  • What Is Ibogaine and Can the Psychedelic Plant Help Break Drug Addictions? (MERRY JANE)

Novel Psychoactive Substances

  • MindMed Initiates Dosing in Human Safety Study of Novel Treatment for Opioid Addiction, 18-MC (The Salamanca Press)

Nitrous Oxide

Ketamine

  • Champignon Brands Acquires Ketamine Clinic Operator AltMed Capital (Benzinga)

  • Can Ketamine-Induced Near-Death Experiences Expedite Healing? (Chacruna)

Miscellaneous

  • Announcing the Launch of the World’s First Psychedelic Video Museum (The Daily Psychedelic Video)

  • Coronavirus triggers UK shortage of illicit drugs (The Guardian)

  • Mindset Pharma Begins Work with Leading R&D Contractor for Next-Generation Psychedelic Drugs (PR Newswire)

  • Coronavirus pandemic could trigger a spike in mental illness — this organisation thinks psychedelic drugs will help (Australian Broadcasting Corporation)

  • Therapists See Benefits and Risks in Psychedelic Therapy During Covid-19 Crisis (Lucid News)

  • How Psychedelic Drugs Can Help Us Overcome Crisis (Kahpi)

  • Why 2020 is the Year of Psychedelics and Threesomes (DoubleBlind)

  • Teens once again discover that nutmeg can get you high with the #NutmegChallenge (The Daily Dot)

  • 5 Tips For Psychedelic Integration Providers (Maps of the Mind)

  • Social Isolation Turns the World Inside Out. That’s Why Shamans Do It. (Kahpi)

  • Ensuring Psychedelic Liberty in Black and Brown Communities: Questions to Ponder (Chacruna)

  • The COVID 19 Journey is a Psychedelic Experience (Medium)

  • UCSB Psychedelics Club Explores Psychedelic Usage and Research (The Bottom Line)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.10.20

ThisWeekinPsychedelics.png

Cannabis

  • Delaware Approves Medical Cannabis Delivery Option (NORML)

  • New York Legal Marijuana Push ‘Effectively Over’ For 2020, Governor Says (Forbes)

  • North Dakota Activists Say Marijuana Legalization Initiative Unlikely In 2020 Due To Coronavirus (Marijuana Moment)

  • Cannabis Workers Claim Unsafe Conditions After Testing Positive for Coronavirus (MERRY JANE)

  • Participate in a Confidential Survey Assessing Cannabis Use Patterns During the COVID-19 Pandemic (NORML)

  • More People Are Seeking Medical Marijuana Cards Amid Coronavirus Outbreak (WBUR)

  • Coronavirus gave cannabis companies a big bump in sales and it wasn’t just for the wake-and-bake set (Fortune)

  • DEA loosens rules on prescription CBD drug Epidiolex (Leafly)

  • Adult-Use Pot Shops Are Supplying Medical Dispensaries with Weed During Pandemic (MERRY JANE)

  • Colorado Girl Who Inspired 'Charlotte's Web' Medical Marijuana Oil Dies at 13 (TIME)

  • Legal Marijuana States Had Fewer Vaping-Related Lung Injuries, Study Finds (Marijuana Moment)

  • Trump Hires Anti-Marijuana White House Press Secretary (Forbes)

  • Legalisation of cannabis in America has led to surge of drug imports to UK, reveals National Crime Agency (The Telegraph)

  • DEA continues to make empty promises on clinical cannabis research (The Hill)

  • Two Marijuana Magazines Owned By High Times Suspend Publication Due To Coronavirus (Marijuana Moment)

  • Septic shock: Did tainted CBD contribute to this woman’s death? (Leafly)

  • FBI Policy On CBD Use By Agents Is ‘Under Review’ (Marijuana Moment)

  • Ireland's Drug Users Switching From Cocaine to Cannabis Amid COVID-19 Crisis (MERRY JANE)

  • Arizona Legal Marijuana Campaign Asks Supreme Court To Allow Electronic Signatures Amid Coronavirus (Marijuana Moment)

  • Florida researchers studying COVID-19 impact on marijuana users (KNOE)

  • Businesses That ‘Indirectly’ Work With Marijuana Industry Ineligible For Federal Coronavirus Loans (Marijuana Moment)

  • Rats develop cannabis-seeking behavior (Medical News Today)

  • Cannabis Withdrawal Syndrome Prevalent Among Regular Users (MD Magazine)

Magic Mushrooms

  • A single high dose of psilocybin alters brain function up to one month later (PsyPost)

  • Psilocybin Is Better at Treating Depression Than Ketamine, New Study Finds (MERRY JANE)

  • New Biosynthesis of Psilocybin and Related Tryptamines (Psychedelic Science Review)

  • Challenges to a Company’s Psilocybin Patent Highlight Contrasting Business Strategies for Developers of Psychedelic Therapies (Lucid News)

  • Psilocybin Superior to Ketamine for Prolonged Antidepressant-Like Effects (Rodent Model) (Psychedelic Science Review)

  • Beyond Psilocybe Cubensis: 10 Magic Mushroom Strains You Should Know About (DoubleBlind)

  • Treating Trauma with Psilocybin (Oregon Daily Herald)

  • How Microdosing Magic Mushrooms Can Change Your Life (VENTS Magazine)

DMT

  • This Startup is Developing a DMT-Based Addiction Treatment (DoubleBlind)

Ayahuasca

  • The Ultimate Guide to Iowaska (Ayahuasca) (Kahpi)

  • Ayahuasca and the Amazon (LIMINAL)

Peyote

  • Southern Comfort: Why People in Rural Alabama Are Turning to Peyote Instead of Therapy (MERRY JANE)

Iboga

  • Interview about Bwiti initiation and iboga with Nima Grégory Puente (LIMINAL)

Ketamine

  • A Disgraced Ex-Doctor Says He's Behind the Use of Ketamine to 'Cure' a Child with Autism (VICE)

  • IV Esketamine, Ketamine Equally Effective for Resistant Depression (Medscape)

Datura

  • Twelve taken ill after consuming ‘coronavirus shaped’ datura seeds (The Hindu)

Miscellaneous

  • We Could Be Taking Psychedelics to Help Treat Mental Illness in Just Five Years (Newsweek)

  • Why coronavirus is making people hoard illegal drugs (Citizen TV)

  • Amidst Pandemic, Psychedelic Investor Christan Angermayer Can't Imagine Life Beyond Capitalism (Psymposia)

  • Psychedelic drugs like LSD and magic mushrooms could help treat mental health issues, study claims (Metro)

  • How Israel has become an unexpected leader in medicinal psychedelics (ISRAEL21c)

  • How psychedelic clinical trials are being affected by coronavirus (Psymposia)

  • National Psychedelics Advocacy Group Takes Next Step In Movement (Marijuana Moment)

  • Scientists Discover Intricacies of Serotonin Receptor Crucial for Better Therapeutics (UNC Health and UNC School of Medicine Newsroom)

  • If You Can’t Go Out, Go In: How Psychedelics Make Quarantine a Time of Self Renewal (DoubleBlind)

  • Why Some People Have Weird Drug Reactions (VICE)

  • Life During Lockdown: Psychedelics, Prison and COVID-19 (Scales)

  • Field Trip Psychedelics Inc. Announces Creation of Field Trip Discovery, the Company's Drug Development Division (PR Newswire)

  • Psychedelics in Addiction Recovery: Taking a Deep Look at “Sober” Communities that Use Psychedelics (Psychedelics Today)

  • Integration: The Upside of Coming Down – Debriefing, Disrupting & Dark Journeys (Chacruna)

  • Should FDA Fast-Track Psychedelic Treatment Under Coronavirus Pandemic? (The Fresh Toast)

  • Magic mushrooms, ayahuasca and LSD can all act as catalysts of connection to the natural world (Ecohustler)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 4.3.20

ThisWeekinPsychedelics.png

Cannabis

  • New York drops legalization from budget, likely ending 2020 push (Leafly)

  • Lack of protective gear at cannabis labs could threaten weed supply (The London Free Press)

  • Scientists Sue DEA Over Alleged ‘Secret’ Document That Delayed Marijuana Research Expansion (Marijuana Moment)

  • Idaho Activists Suspend Campaign To Legalize Medical Marijuana Due To Coronavirus (Marijuana Moment)

  • Boise startup reworks CBD and THC testing technology to test for COVID-19 in minutes (KTVB)

  • Missouri Marijuana Legalization Campaign In Jeopardy Due To Coronavirus (Marijuana Moment)

  • Cannabis users, shops suffer high anxiety after Massachusetts shuts down recreational sales (NBC News)

  • FDA Warns Former NFL Player To Stop Claiming CBD Can Cure Coronavirus (Marijuana Moment)

  • More Than 90% of Legal Marijuana Products Too Strong for Chronic Pain Relief (SciTechDaily)

  • Virginia Groups Push Governor To Amend Marijuana Decriminalization Bill On His Desk (Marijuana Moment)

  • Cannabis Scientists Are Chasing the Perfect High (The New York Times)

  • Senate Housing Bill Would Prevent Evictions For State-Legal Marijuana Extraction (Marijuana Moment)

  • Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent (NORML)

  • Large international study finds cannabis use is linked to lower physical activity levels in adolescents (PsyPost)

  • Cannabis license application deadline extended due to COVID-19 pandemic (WLS-TV)

  • Study sheds light on common adverse reactions to cannabis (News Medical)

  • How cannabis and humans evolved together (Leafly)

  • Teen Weed Smokers May Have Trouble Falling Asleep as Adults, New Study Says (MERRY JANE)

  • New Medicinal Cannabis Rules Launch in New Zealand (The Cannabis Exchange)

  • Washington Governor Signs Bill To Diversify State’s Marijuana Industry (Marijuana Moment)

  • Study indicates vaporized cannabis creates drug-seeking behavior (Brinkwire)

  • Feds Funding Research On How Marijuana Consumers Are Impacted By Coronavirus (Marijuana Moment)

  • Arbitrary & excessive: Marijuana trafficking sentences in Alabama (Southern Poverty Law Center)

LSD

  • This New York City Pharma Startup Wants To Turn LSD Into An FDA-Approved Medicine For Anxiety Disorder (Forbes)

  • MindMed Acquires Exclusive License to Eight Clinical Trials of LSD, Partners with World-Leading Psychedelic Research Laboratory at University Hospital Basel (Yahoo! Finance)

  • From Aldous Huxley to the Beatles: how LSD has inspired art (The Guardian)

Magic Mushrooms

  • Psilocybin Mindfulness Negatively Correlated with 5-HT2A Binding, Study Finds (Psychedelic Science Review)

  • Champignon Brands To Acquire Psilocybin Research Firm Tassili Life Sciences (The Deep Dive)

  • As Health-Conscious Consumers Seek Fresh Nutritional Avenues, Artisanal Mushrooms Step Into the Light (PR Newswire)

  • Psilocybin Kitchen: The Basics of Cooking with Mushrooms (DoubleBlind)

  • Understanding the Buzz About Magic Mushrooms (Psychology Today)

MDMA

Ayahuasca

  • Drinking Ayahuasca Without DMT is Powerful and Traditional (Kahpi)

Peyote

  • Why are some Native Americans fighting efforts to decriminalize peyote? (Los Angeles Times)

Iboga

  • Clear Sky Recovery Featured in the Documentary Ibogaine: Cure for a Crisis (PRWeb)

  • How psychedelic medicine is being used in the fight to end opioid addiction (EPM Magazine)

Ketamine

Miscellaneous

  • Coronavirus Upends Marijuana, Psychedelics And Drug Reform Ballot Measures (Forbes)

  • A New Breed of Drug Dealer Has Turned Buying Drugs into a Treasure Hunt (VICE)

  • DC Activists Have A New Plan To Get Psychedelics Decriminalization On The Ballot Despite Coronavirus (Marijuana Moment)

  • People with low psychological well-being more likely to report positive outcomes after psychedelic use (PsyPost)

  • Coronavirus, Drugs, and the Future of Festivals (DanceSafe)

  • Understanding Drug Potency and Its Importance in Psychedelic Research (Psychedelic Science Review)

  • Ehave, Inc. Appoints Dr. Mark Braunstein as Chief Psychedelic Officer (Yahoo! Finance)

  • Comparing Aeruginascin and Bufotenidine (Psychedelic Science Review)

  • Ease rules on research into psychedelic drugs, urges David Nutt (The Guardian)

  • An Insight into Drug Testing Facilities in the Netherlands (Volteface)

  • The Structure and Function of the Serotonin 5-HT2B Receptor (Psychedelic Science Review)

  • Ex-Cheerleader Jackee Stang Just Launched the ‘Goop of Psychedelics’ (The Daily Beast)

  • Can psychedelic therapy reduce the mental health impacts of the coronavirus pandemic? (The Sacramento Bee)

  • Revisiting the potential of using psychedelic drugs in psychiatry (Medical Xpress)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.27.20

ThisWeekinPsychedelics.png

Cannabis

  • Coronavirus Crisis Shows Marijuana Is ‘Essential’ And Mainstream (Forbes)

  • Ghana legalizes cannabis for health and industrial purposes (GhanaWeb)

  • Coronavirus Is Killing Weed Legalization Bills Across the US (MERRY JANE)

  • Nebraska Medical Marijuana Campaign Suspended Due To Coronavirus (Marijuana Moment)

  • Mass. Gov. Closes Adult-Use Pot Shops During Virus Crisis (Law360)

  • South Dakota Marijuana Legalization Campaign Urges Absentee Voting Amid Coronavirus (Marijuana Moment)

  • Cannabis Industry Workers May Be at Risk of Respiratory Issues, New Study Says (MERRY JANE)

  • Marijuana Businesses Are Ineligible For Coronavirus Disaster Relief, Federal Agency Confirms (Marijuana Moment)

  • Mapping the cannabis genome to improve crops and health (Phys.org)

  • Federal Agency Wants Help Developing A Standard THC Dose For Marijuana Products (Marijuana Moment)

  • NORML Launches “Smoke the Vote” To Prepare For 2020 Election (NORML)

  • Feds Prosecuted Even Fewer Marijuana Cases In 2019 As More States Legalize, New Data Shows (Marijuana Moment)

  • Raleigh mayor lit up for posting a picture with a weed pen in it (The Daily Dot)

  • Curbside cannabis pickup: Why it’s booming and how it works (Leafly)

  • Youth Marijuana Treatment Admissions Fell After Legalization, Study Finds (Marijuana Moment)

  • Cannabis sales hit new highs in US and Canada (New York Post)

  • DEA Unveils New Rule To Finally Allow More Marijuana Growers For Research (Marijuana Moment)

  • Coronavirus: Massachusetts marijuana dispensaries to make, donate hand sanitizer to hospitals during COVID-19 pandemic (MassLive)

  • Study indicates vaporized cannabis creates drug-seeking behavior (WSU Insider)

  • Arizona Marijuana Activists Have More Than Enough Signatures To Put Legalization On Ballot, They Say (Marijuana Moment)

  • Exploring the 3 Different Types of Cannabinoids: Endo, Phyto, and Synthetic (CBD Testers)

  • Fired NFL Players Want Their Jobs Back After the League Changed Its Drug Policy (MERRY JANE)

  • Can Medical Cannabis Be Used to Treat Acute Pain? (Pain News Network)

LSD

  • George Harrison discusses LSD and The Beatles on the Dick Cavett Show in 1971 (Far Out Magazine)

Magic Mushrooms

  • Redesigning Psychedelic Mushrooms to Never Cause a “Bad Trip” (DoubleBlind)

  • Oregon Campaign To Legalize Psilocybin Mushrooms For Therapeutic Use Hits Snag Amid Coronavirus (Marijuana Moment)

  • Denver Government Psilocybin Panel Sets Criteria To Track Decriminalization’s Impact (Marijuana Moment)

MDMA

  • Veterans and first responders report lasting personal benefits after MDMA-assisted psychotherapy (PsyPost)

  • Healing PTSD with MDMA Therapy (Veterans News Report)

Ayahuasca

  • Actress Dayle McLeod releases Memoir about An Ayahuasca Trip that sent her to the Psyche Ward and Unleashed her Creativity (PR Urgent)

Salvia Divinorum

  • What Is Salvia, and Is the Psychoactive Drug Still Legal? (MERRY JANE)

Novel Psychoactive Substances

  • MindMed Advances 18-MC, Potential Treatment for Opioid Addiction, Into Further Clinical Testing (PR Newswire)

Ketamine

  • COVID-19 And Mental Health: How To Get Ketamine-Based Psychedelic Therapy From Home Using An App (Forbes)

  • Champignon Brands Expands Alternative Medicine Ip Portfolio With Ketamine, Adaptogenic Delivery Systems/Formulations (GlobeNewswire)

Miscellaneous

  • You're Socially Isolating. Is Now a Good Time to Trip on Psychedelics? (VICE)

  • Psychedelics in Palliative Care (Scientific American)

  • Drug Dealers Say Coronavirus Is Already Affecting Supply and Demand (VICE)

  • Oregon Drug Decriminalization And Treatment Campaign Impacted By Coronavirus (Marijuana Moment)

  • Cellular Receptors and Their Role in the Psychedelic Effect (Psychedelic Science Review)

  • How coronavirus is changing the market for illegal drugs (The Conversation)

  • What Psychedelics Told Me About The Coronavirus (Medium)

  • Ayahuasca Healings’ Trinity de Guzman calls coronavirus “a necessary purge” (Psymposia)

  • Urine survey reveals Europe’s favorite drugs (Big Think)

  • Why Black People Should Embrace Psychedelic Healing: Reclaiming Our Cultural Birthright (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.